Literature DB >> 18311353

An Internet-based symptom questionnaire that is reliable, valid, and available to psychiatrists, neurologists, and psychologists.

C Thomas Gualtieri1.   

Abstract

The Neuropsych Questionnaire (NPQ) addresses 2 important clinical issues: how to screen patients for a wide range of neuropsychiatric disorders quickly and efficiently, and how to acquire independent verification of a patient's complaints. The NPQ is available over the Internet in adult and pediatric versions. The adult version of the NPQ consists of 207 simple questions about common symptoms of neuropsychiatric disorders. The NPQ scores patient and/or observer responses in terms of 20 symptom clusters: inattention, hyperactivity-impulsivity, learning problems, memory, anxiety, panic, agoraphobia, obsessions and compulsions, social anxiety, depression, mood instability, mania, aggression, psychosis, somatization, fatigue, sleep, suicide, pain, and substance abuse. The NPQ is reliable (patients tested twice, patient-observer pairs, 2 observers) and discriminates patients with different diagnoses. Scores generated by the NPQ correlate reasonably well with commonly used rating scales, and the test is sensitive to the effects of treatment. The NPQ is suitable for initial patient evaluations, and a short form is appropriate for follow-up assessment. The availability of a comprehensive computerized symptom checklist can help to make the day-to-day practice of psychiatry, neurology, and neuropsychology more objective.

Entities:  

Mesh:

Year:  2007        PMID: 18311353      PMCID: PMC2234274     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  8 in total

1.  Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences.

Authors:  C C Preston; A M Colman
Journal:  Acta Psychol (Amst)       Date:  2000-03

2.  Rating scales, discriminability, and information transmission.

Authors:  W R GARNER
Journal:  Psychol Rev       Date:  1960-11       Impact factor: 8.934

3.  Neurocognitive testing supports a broader concept of mild cognitive impairment.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  Am J Alzheimers Dis Other Demen       Date:  2005 Nov-Dec       Impact factor: 2.035

4.  Will physician-level measures of clinical performance be used in medical malpractice litigation?

Authors:  Aaron S Kesselheim; Timothy G Ferris; David M Studdert
Journal:  JAMA       Date:  2006-04-19       Impact factor: 56.272

5.  Neurocognition in depression: patients on and off medication versus healthy comparison subjects.

Authors:  C Thomas Gualtieri; Lynda G Johnson; Kenneth B Benedict
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

6.  Use of standardised outcome measures in adult mental health services: randomised controlled trial.

Authors:  Mike Slade; Paul McCrone; Elizabeth Kuipers; Morven Leese; Sharon Cahill; Alberto Parabiaghi; Stefan Priebe; Graham Thornicroft
Journal:  Br J Psychiatry       Date:  2006-10       Impact factor: 9.319

Review 7.  The Hamilton Depression Rating Scale: has the gold standard become a lead weight?

Authors:  R Michael Bagby; Andrew G Ryder; Deborah R Schuller; Margarita B Marshall
Journal:  Am J Psychiatry       Date:  2004-12       Impact factor: 18.112

8.  Efficient allocation of attentional resources in patients with ADHD: maturational changes from age 10 to 29.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  J Atten Disord       Date:  2006-02       Impact factor: 3.256

  8 in total
  5 in total

1.  Use of the internet to assist in the treatment of depression and anxiety: a systematic review.

Authors:  Alan G Wade
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Retrospective Case Series of Traumatic Brain Injury and Post-Traumatic Stress Disorder Treated with Hyperbaric Oxygen Therapy.

Authors:  R Douglas Shytle; David J Eve; Soel-Hee Kim; Allan Spiegel; Paul R Sanberg; Cesar V Borlongan
Journal:  Cell Transplant       Date:  2019-05-28       Impact factor: 4.064

3.  Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for Triage.

Authors:  Karen Blackmon; Gregory S Day; Harry Ross Powers; Wendelyn Bosch; Divya Prabhakaran; Dixie Woolston; Otto Pedraza
Journal:  Res Sq       Date:  2022-02-07

4.  Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage.

Authors:  Karen Blackmon; Gregory S Day; Harry Ross Powers; Wendelyn Bosch; Divya Prabhakaran; Dixie Woolston; Otto Pedraza
Journal:  BMC Neurol       Date:  2022-07-30       Impact factor: 2.903

5.  No personalization without participation: on the active contribution of psychiatric patients to the development of a mobile application for mental health.

Authors:  Jean-François Pelletier; Michael Rowe; Nathe François; Julie Bordeleau; Sonia Lupien
Journal:  BMC Med Inform Decis Mak       Date:  2013-07-27       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.